First Treatment for Demodex Blepharitis Wins FDA Approval

(MedPage Today) -- The FDA approved lotilaner ophthalmic solution 0.25% (Xdemvy) as the first specific treatment for Demodex blepharitis. Lotilaner (formerly TP-03) is an ectoparasiticide that targets Demodex mites, which invade and reside in...
Source: MedPage Today Public Health - Category: American Health Source Type: news